Currently, there has been a surge in posts about GC Cell on portal sites and stock market communities. As of today, foreign investors are estimated to have made a net sale of 6,000 shares. GC Cell is known as a company that develops and manufactures cancer immunotherapy cell treatments.


As of 1:30 p.m. on January 5, 2021, GC Cell's stock price is 55,100 KRW, down 8.62% from the previous day. The trading volume stands at 1,095,243 shares, which is 57.86% of the five-day average trading volume.


In addition to GC Cell, there has also been a sharp increase in posts from investors regarding WIZIT (036090), Sinsung Delta Tech (065350), and Anam Electronics (008700).



※ Source: AI investment assistant AI Rasilo


※ This article was automatically generated in real time by a news automation algorithm jointly developed by Asia Economy and the financial AI company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing